These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 8956382

  • 1. Ritanserin in the treatment of alcohol dependence--a multi-center clinical trial. Ritanserin Study Group.
    Johnson BA, Jasinski DR, Galloway GP, Kranzler H, Weinreib R, Anton RF, Mason BJ, Bohn MJ, Pettinati HM, Rawson R, Clyde C.
    Psychopharmacology (Berl); 1996 Nov; 128(2):206-15. PubMed ID: 8956382
    [Abstract] [Full Text] [Related]

  • 2. Ritanserin in relapse prevention in abstinent alcoholics: results from a placebo-controlled double-blind international multicenter trial. Ritanserin in Alcoholism Work Group.
    Wiesbeck GA, Weijers HG, Chick J, Naranjo CA, Boening J.
    Alcohol Clin Exp Res; 1999 Feb; 23(2):230-5. PubMed ID: 10069551
    [Abstract] [Full Text] [Related]

  • 3. Ritanserin, a central 5-HT2 antagonist, in heavy social drinkers: desire to drink, alcohol intake and related effects.
    Naranjo CA, Poulos CX, Lanctôt KL, Bremner KE, Kwok M, Umana M.
    Addiction; 1995 Jul; 90(7):893-905. PubMed ID: 7663312
    [Abstract] [Full Text] [Related]

  • 4. Ritanserin in the treatment of cocaine dependence.
    Johnson BA, Chen YR, Swann AC, Schmitz J, Lesser J, Ruiz P, Johnson P, Clyde C.
    Biol Psychiatry; 1997 Nov 15; 42(10):932-40. PubMed ID: 9359980
    [Abstract] [Full Text] [Related]

  • 5. Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trial.
    Akhondzadeh S, Mohajari H, Reza Mohammadi M, Amini H.
    BMC Psychiatry; 2003 Jun 19; 3():7. PubMed ID: 12816549
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Failure of ritanserin to block cocaine cue reactivity in humans.
    Ehrman RN, Robbins SJ, Cornish JW, Childress AR, O'Brien CP.
    Drug Alcohol Depend; 1996 Nov 19; 42(3):167-74. PubMed ID: 8912799
    [Abstract] [Full Text] [Related]

  • 8. Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.
    Namkoong K, Lee BO, Lee PG, Choi MJ, Lee E.
    Alcohol Alcohol; 2003 Nov 19; 38(2):135-41. PubMed ID: 12634260
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 5-HT2 receptor antagonism in dysthymic disorder: a double-blind placebo-controlled study with ritanserin.
    Bersani G, Pozzi F, Marini S, Grispini A, Pasini A, Ciani N.
    Acta Psychiatr Scand; 1991 Apr 19; 83(4):244-8. PubMed ID: 1903019
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM, Cornelius JR, Daley DC, Kirisci L, Himmelhoch JM, Thase ME.
    Arch Gen Psychiatry; 2005 Jan 19; 62(1):37-45. PubMed ID: 15630071
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A pilot trial of the alpha-1 adrenergic antagonist, prazosin, for alcohol dependence.
    Simpson TL, Saxon AJ, Meredith CW, Malte CA, McBride B, Ferguson LC, Gross CA, Hart KL, Raskind M.
    Alcohol Clin Exp Res; 2009 Feb 19; 33(2):255-63. PubMed ID: 18945226
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.